Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 9/2013

01-11-2013 | Substantive Review

Microenterprise Development Interventions for Sexual Risk Reduction: A Systematic Review

Authors: Rosa R. Cui, Ramon Lee, Harsha Thirumurthy, Kathryn E. Muessig, Joseph D. Tucker

Published in: AIDS and Behavior | Issue 9/2013

Login to get access

Abstract

Comprehensive interventions that address both individual and structural determinants associated with HIV/STI risk are gaining increasing attention over the past decade. Microenterprise development offers an appealing model for HIV prevention by addressing poverty and gender equality. This study systematically reviewed the effects of microenterprise development interventions on HIV/STI incidence and sexual risk behaviors. Microenterprise development was defined as developing small business capacity among individuals to alleviate poverty. Seven eligible research studies representing five interventions were identified and included in this review. All of the studies targeted women, and three focused on sex workers. None measured biomarker outcomes. All three sex worker studies showed significant reduction in sexual risk behaviors when compared to the control group. Non-sex worker studies showed limited changes in sexual risk behavior. This review indicates the potential utility of microenterprise development in HIV risk reduction programs. More research is needed to determine how microenterprise development can be effectively incorporated in comprehensive HIV control strategies.
Literature
1.
Gillespie S, Kadiyala S, Greener R. Is poverty or wealth driving HIV transmission? AIDS. 2007;21(Suppl 7):S5–16.PubMedCrossRef
2.
Greig A, Peacock D, Jewkes R, Msimang S. Gender and AIDS: time to act. AIDS. 2008;22(Suppl 2):S35–43.PubMedCrossRef
3.
Kim JC, Watts CH, Hargreaves JR, et al. Understanding the impact of a microfinance-based intervention on women’s empowerment and the reduction of intimate partner violence in South Africa. Am J Public Health. 2007;97(10):1794–802.PubMedCrossRef
4.
Stratford D, Mizuno Y, Williams K, Courtenay-Quirk C, O’Leary A. Addressing poverty as risk for disease: recommendations from CDC’s consultation on microenterprise as HIV prevention. Public Health Reports. 2008;123(1):9–20.PubMed
5.
Gupta GR, Parkhurst JO, Ogden JA, Aggleton P, Mahal A. Structural approaches to HIV prevention. Lancet. 2008;372(9640):764–75.PubMedCrossRef
6.
UNAIDS. Combination HIV prevention: tailoring and coordinating biomedical, behavioral, and structural strategies to reduce new HIV infections. A UNAIDS discussion paper 2010.
7.
Coates TJ, Richter L, Caceres C. Behavioural strategies to reduce HIV transmission: how to make them work better. Lancet. 2008;372(9639):669–84.PubMedCrossRef
8.
Pronyk PM, Hargreaves JR, Kim JC, et al. Effect of a structural intervention for the prevention of intimate-partner violence and HIV in rural South Africa: a cluster randomised trial. Lancet. 2006;368(9551):1973–83.PubMedCrossRef
9.
Dworkin SL, Blankenship K. Microfinance and HIV/AIDS prevention: assessing its promise and limitations. AIDS Behav. 2009;13(3):462–9.PubMedCrossRef
10.
Kim J, Pronyk P, Barnett T, Watts C. Exploring the role of economic empowerment in HIV prevention. AIDS. 2008;22(Suppl 4):S57–71.PubMedCrossRef
11.
Khandker S. Microfinance and poverty: evidence using panel data from Bangladesh.2005 Vol 19: Oxford University Press.
12.
13.
Chowdhury A. Microfinance as a poverty reduction tool—a critical assessment. Vol DESA Working Paper No. 892009.
14.
Karlan D, Murdoch J. Access to finance. Vol 52009.
15.
Banerjee AV, Duflo E, Glennerster R, Kinnan C. The miracle of microfinance? Evidence from a randomized evaluation. 2013. Accessed April 14.
16.
Robinson M. The microfinance revolution: sustainable finance for the poor. The World Bank, Washington DC2001.
17.
Johnson S. Gender impact assessment in microfinance and microenterprise: why and how. Dev Pract. 2000;10(1):89–93.PubMedCrossRef
18.
Auerbach J. Transforming social structures and environments to help in HIV prevention. Health affairs (Project Hope). 2009;28(6):1655–65.CrossRef
19.
Hankins CA, de Zalduondo BO. Combination prevention: a deeper understanding of effective HIV prevention. AIDS. 2010;24(Suppl 4):S70–80.PubMedCrossRef
20.
Vergidis PI, Falagas ME. Meta-analyses on behavioral interventions to reduce the risk of transmission of HIV. Infect Dis Clin North Am. 2009;23(2):309–14.PubMedCrossRef
21.
Sherman SG, Srikrishnan AK, Rivett KA, Liu SH, Solomon S, Celentano DD. Acceptability of a microenterprise intervention among female sex workers in Chennai. India. AIDS and behavior. 2010;14(3):649–57.CrossRef
22.
Kim J, Ferrari G, Abramsky T, et al. Assessing the incremental effects of combining economic and health interventions: the IMAGE study in South Africa. Bull World Health Organ. 2009;87(11):824–32.PubMedCrossRef
23.
Pronyk PM, Kim JC, Abramsky T, et al. A combined microfinance and training intervention can reduce HIV risk behaviour in young female participants. AIDS. 2008;22(13):1659–65.PubMedCrossRef
24.
West S. Systems to rate the strength of scientific evidence. Evidence Report/Technology Assessment No. 47 (Prepared by the Research Triangle Institute- University of North Carolina Evidence-based Practice under Contract No. 290-97-0011). AHRQ Publication No. 02-E016. April 2002.
25.
Rosenberg MS, Seavey BK, Jules R, Kershaw TS. The role of a microfinance program on HIV risk behavior among Haitian women. AIDS Behav. 2011;15(5):911–8.PubMedCrossRef
26.
Odek WO, Busza J, Morris CN, Cleland J, Ngugi EN, Ferguson AG. Effects of micro-enterprise services on HIV risk behaviour among female sex workers in Kenya’s urban slums. AIDS Behav. 2009;13(3):449–61.PubMedCrossRef
27.
Sherman SG, German D, Cheng Y, Marks M, Bailey-Kloche M. The evaluation of the JEWEL project: an innovative economic enhancement and HIV prevention intervention study targeting drug using women involved in prostitution. AIDS care. 2006;18(1):1–11.PubMedCrossRef
28.
Dunbar MS, Maternowska MC, Kang MS, Laver SM, Mudekunye-Mahaka I, Padian NS. Findings from SHAZ!: a feasibility study of a microcredit and life-skills HIV prevention intervention to reduce risk among adolescent female orphans in Zimbabwe. J prev interv community. 2010;38(2):147–61.PubMedCrossRef
29.
Isangula KG. Improving women and family’s health through integrated microfinance, health education and promotion in rural areas. J Sustain Develop. 2012.
30.
Pulerwitz J. Measuring sexual relationship power in HIV/STD research. Sex Roles. 2000;42(7/8):637–60.CrossRef
31.
Coppock DL, Desta S, Tezera S, Gebru G. Capacity building helps pastoral women transform impoverished communities in Ethiopia. Science. 2011;334(6061):1394–8.PubMedCrossRef
32.
Isangula KG. Improving women and family’s health through integrated microfinance, health education and promotion in rural areas. J Sustain Develop. 2012;5(5):76–89.
33.
Mayoux L. Women’s empowerment and micro-finance programmes: strategies for increasing impact. Dev Pract. 1998;8(2):235–41.PubMedCrossRef
34.
Pitt M, Khandker S. The impact of group—based credit programs on poor households in Bangladesh: does the gender of participants matter? J Political Econ. 1998;106(5):958–96.CrossRef
35.
de Mel S, McKenzie D, Woodruff C. Are women more credit constrained? Experimental evidence on gender and microenterprise returns. Am Econ J: Appl Econ. 2009;1(3):1–32.CrossRef
36.
de Mel S, McKenzie D, Woodruff C. Returns to capital in microenterprise: evidence from a field experiment. Q J Econ. 2008;123(4):1329–72.CrossRef
37.
Armendariz B. Gender empowerment in microfinance: Harvard University; 2008.
38.
Goetz S, Gupta R. Who takes the credit? gender, power, and control over loan use in rural credit programs in Bangladesh. World Dev. 1996;24(1):45–63.CrossRef
39.
Jewkes R, Nduna M, Levin J, et al. Impact of stepping stones on incidence of HIV and HSV-2 and sexual behaviour in rural South Africa: cluster randomised controlled trial. BMJ (Clinical research ed.). 2008;337:a506.
40.
Pulerwitz J, Michaelis A, Verma R, Weiss E. Addressing gender dynamics and engaging men in HIV programs: lessons learned from Horizons research. Public health reports. 2010;125(2):282–92.PubMed
41.
Verma RK, Pulerwitz J, Mahendra V, et al. Challenging and changing gender attitudes among young men in Mumbai, India. Reproductive health matters. 2006;14(28):135–43.PubMedCrossRef
Metadata
Title
Microenterprise Development Interventions for Sexual Risk Reduction: A Systematic Review
Authors
Rosa R. Cui
Ramon Lee
Harsha Thirumurthy
Kathryn E. Muessig
Joseph D. Tucker
Publication date
01-11-2013
Publisher
Springer US
Published in
AIDS and Behavior / Issue 9/2013
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-013-0582-1

Other articles of this Issue 9/2013

AIDS and Behavior 9/2013 Go to the issue

Original Paper

Use of a Novel Technology to Track Adherence to Product Use in a Microbicide Trial of Short Duration (MTN-007)

Original Paper

Reaching Men Who Have Sex with Men: A Comparison of Respondent-Driven Sampling and Time-Location Sampling in Guatemala City

Original Paper

Synthesizing Gender Based HIV Interventions in Sub-Sahara Africa: A Systematic Review of the Evidence

Original Paper

WiLLOW: Reaching HIV-Positive African-American Women Through a Computer-Delivered Intervention

Original Paper

Summary Measures of Adherence Using Pill Counts in Two HIV Prevention Trials: The Need for Standardisation in Reporting

Commentary

To Weight or Not to Weight in Time-location Sampling: Why Not Do Both?
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits